Bausch Health Companies (TSE:BHC) Stock Price Up 1.7%

Bausch Health Companies Inc. (TSE:BHCGet Free Report)’s stock price traded up 1.7% on Monday . The company traded as high as C$8.84 and last traded at C$8.82. 215,211 shares changed hands during mid-day trading, a decline of 39% from the average session volume of 352,359 shares. The stock had previously closed at C$8.67.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada upped their target price on shares of Bausch Health Companies from C$8.00 to C$9.00 and gave the stock a “sector perform” rating in a research report on Friday, February 23rd.

Read Our Latest Research Report on BHC

Bausch Health Companies Stock Up 1.7 %

The stock’s 50-day moving average price is C$10.08 and its two-hundred day moving average price is C$11.01. The stock has a market capitalization of C$3.24 billion, a PE ratio of -5.22, a P/E/G ratio of 0.21 and a beta of 0.90. The company has a debt-to-equity ratio of 7,583.76, a quick ratio of 0.58 and a current ratio of 1.23.

Bausch Health Companies (TSE:BHCGet Free Report) last released its earnings results on Thursday, May 2nd. The company reported C$0.80 earnings per share for the quarter, missing analysts’ consensus estimates of C$1.02 by C($0.22). Bausch Health Companies had a negative return on equity of 686.52% and a negative net margin of 5.07%. The business had revenue of C$2.90 billion during the quarter, compared to analysts’ expectations of C$2.98 billion. As a group, analysts expect that Bausch Health Companies Inc. will post 4.85 EPS for the current fiscal year.

Bausch Health Companies Company Profile

(Get Free Report)

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.

Further Reading

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with's FREE daily email newsletter.